🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Sixfold is at NeurIPS Conference! Please come check out the work of Dr Vidhi Lalchand, at the Women in Machine Learning (WiML) workshop. She’ll be presenting our research on 11th of Dec from 3:30pm - 4pm in the Great Hall (poster number #20). For more info: lnkd.in/esitG4vs

We’re excited to announce the appointment of David Ellam as CFO (fractional). David has held several senior finance roles within both US & UK privately and publicly owned life-science companies. Read more here: sixfold.bio/post/sixfold-b…

The December issue is here! Free for a limited time! -50 years of recombinant DNA Cold Spring Harbor Laboratory -LNP in vivo prime editing ErikSontheimerLab -Extracellular RNA transport Sixfold bioscience -Spatial epigenomic mapping AtlasXomics -...and more! Cover by Yee Mon Oo! liebertpub.com/toc/genbio/2/6

In GEN Biotechnology, Sixfold bioscience team members Alice Ghidini & Aleksandra Singh highlight the RNA transport pathway that serves as the inspiration for Sixfold’s revolutionary new technology. Read on to learn more: liebertpub.com/doi/epdf/10.10…

#RNA delivery is hard. But what if there were ready-made mechanisms in the human body that naturally transport RNA? In an article published yesterday in GEN Biotechnology Sixfold bioscience reviews the 'RNA Recognition Pathway' and its implications for #RNAdelivery

Today we announce our new VP of Development, Allison Morgan. Allison brings extensive experience leading the regulatory process for RNA medicines, including a key role in Prosensa's engagements with the FDA. Read more: sixfold.bio/post/sixfold-b…

We are pleased to announce that Neil Lawrence, DeepMind Professor of Machine Learning at Cambridge, has joined our Scientific Advisory Board. Prof Lawrence’s input will ensure we continue to leverage the latest advances in ML/gen. AI for RNA delivery: lnkd.in/eNtEpeuU

We’re delighted to start 2024 by announcing that Dr. Søren Ottosen has joined our team as VP of Research! Søren has deep domain experience in identifying and developing RNA medicines. Read more here: sixfold.bio/post/sixfold-b…

Sixfold has been on the road this month presenting at SLAS and chairing the RNAi-Based Therapeutics Summit! Next up: RNALeaders Europe where Dr Søren Ottosen will present research on our novel RNA delivery system. Read more here: sixfold.bio/news

To wrap up day two of #PULSE2024, we have our panellists sharing their experience of founding a company and acquiring #Investors 🚀 📌 George Foot, CEO & Co-Founder, Sixfold bioscience 📌 Jonathan Kwok, CEO & Co-Founder, Infinitopes 📌Lydia Mapstone, CEO & Co-Founder, BoobyBiome

Start-up Festival returns on 📅 16 May in 📍 #London ➡️ ow.ly/KkAe50R8ncH 📌 Dr Kate Barclay, BioIndustry Association (BIA) 📌 Martin McGurk, Innovate UK 📌 Ioanna Mylonaki, Sixfold bioscience Thank you to HSBC Innovation Banking, Johnson & Johnson, Kadans Science Partner, Kilburn & Strode 👏 #BiotechStartups

Last week Dr. Elena Sanna and Dr. Reeta Daswani presented a collection of talks at the Formulation & Delivery by Oxford Global, showcasing a snapshot of our pioneering research in analytics, automation and CNS #RNAi #delivery.

Our next panel will be discussing essential #skills for building a lean strong #biotech start-up 💪 📌 Dr Kate Barclay, BioIndustry Association (BIA) 📌 Marc Daigneault, Medicines Discovery Catapult 📌 Martin McGurk, Innovate UK 📌 Ionna Mylonaki, Sixfold bioscience #BiotechStartups

Last week Dr Ioanna Mylonaki joined a panel session at the BioIndustry Association (BIA) #StartupFestival to discuss ‘Building skills as part of a lean team’, alongside Innovate UK and Medicines Discovery Catapult, with a brilliant range of topics covered by Kate Barclay on accessing skills and talent in biotech.

Tina (Tina Flatau) is in Boston this week for meetings with investors and partners as part of the UK Life Sciences Trade Mission to Boston, with Grow London / London & Partners. Sixfold Bioscience was selected to showcase the UK’s high growth #TechbBio ecosystem.

Last Tuesday Dr Søren Ottosen joined a panel organised by Oxford Global on "Overcoming The Latest Trends & Challenges In Targeted Oligonucleotide #Delivery", alongside David Evans, Head of Drug Discovery and Collaboration at #Sirnaomics

We are delighted to announce UK Research and Innovation #FLF funding that will support a 4 year project in Generative Machine Learning. Led by Sixfold's Dave Lines, the project will continue our work in applying AI/ML to designing more efficient #RNA #delivery systems: sixfold.bio/post/generativ…

Earlier this month, Dr Ioanna Mylonaki chaired a session at the Annual Conference of the Controlled Release Society 2024 in Bologna. This session featured speakers from the #CRS Gene Delivery and Gene Editing Focus group, where Ioanna serves on the board. #CRS2024 #Delivery

Last month we presented our work with MIT and Cambridge on generative modelling at the #ICML #NGSM workshop. Read more: sixfold.bio/post/sixfold-b… #RNADelivery #AI #ML

Last Thursday Dr Søren Ottosen, VP Research, presented our research on #RNAdelivery at the '5th Nordic Nucleic Acid Based Medicine Industry Network Meeting' alongside leading scientists from Roche, Novo Nordisk and Lundbeck. Read more: sixfold.bio/post/sixfold-5…